A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome by Hodgson, Carol L et al.
RESEARCH Open Access
A randomised controlled trial of an open lung
strategy with staircase recruitment, titrated PEEP
and targeted low airway pressures in patients
with acute respiratory distress syndrome
Carol L Hodgson
1,2,5*, David V Tuxen
1, Andrew R Davies
1,2, Michael J Bailey
1,2, Alisa M Higgins
2, Anne E Holland
3,5,
Jenny L Keating
4, David V Pilcher
1, Andrew J Westbrook
2, David J Cooper
1,2 and Alistair D Nichol
1,2
Abstract
Introduction: Tidal volume and plateau pressure minimisation are the standard components of a protective lung
ventilation strategy for patients with acute respiratory distress syndrome (ARDS). Open lung strategies, including
higher positive end-expiratory pressure (PEEP) and recruitment manoeuvres to date have not proven efficacious.
This study examines the effectiveness and safety of a novel open lung strategy, which includes permissive
hypercapnia, staircase recruitment manoeuvres (SRM) and low airway pressure with PEEP titration.
Method: Twenty ARDS patients were randomised to treatment or ARDSnet control ventilation strategies. The
treatment group received SRM with decremental PEEP titration and targeted plateau pressure < 30 cm H2O. Gas
exchange and lung compliance were measured daily for 7 days and plasma cytokines in the first 24 hours and on
days 1, 3, 5 and 7 (mean ± SE). Duration of ventilation, ICU stay and hospital stay (median and interquartile range)
and hospital survival were determined.
Results: There were significant overall differences between groups when considering plasma IL-8 and TNF-a. For
plasma IL-8, the control group was 41% higher than the treatment group over the seven-day period (ratio 1.41 (1.11
to 1.79), P = 0.01), while for TNF-a the control group was 20% higher over the seven-day period (ratio 1.20 (1.01 to
1.42) P = 0.05). PaO2/FIO2 (204 ± 9 versus 165 ± 9 mmHg, P = 0.005) and static lung compliance (49.1 ± 2.9 versus
33.7 ± 2.7 mls/cm H2O, P < 0.001) were higher in the treatment group than the control group over seven days. There
was no difference in duration of ventilation (180 (87 to 298) versus 341 (131 to 351) hrs, P = 0.13), duration of ICU
stay (9.9 (5.6 to 14.8) versus 16.0 (8.1 to 19.3) days, P = 0.19) and duration of hospital stay (17.9 (13.7 to 34.5) versus
24.7 (20.5 to 39.8) days, P = 0.16) between the treatment and control groups.
Conclusions: This open lung strategy was associated with greater amelioration in some systemic cytokines,
improved oxygenation and lung compliance over seven days. A larger trial powered to examine clinically-
meaningful outcomes is warranted.
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Acute respiratory distress syndrome (ARDS) is an
inflammatory condition of the lungs that is associated
with high mortality [1]. Mechanical ventilation is a life
supporting intervention that aims to maintain gas
exchange in these patients, but it can also augment or
initiate lung injury [2]. Lung-protective mechanical ven-
tilation strategies that aim to minimise tidal volume and
plateau pressure have been the predominant interven-
tion associated with improved patient survival [3,4].
Clinicians frequently use high positive end-expiratory
pressure (PEEP) to improve alveolar recruitment in
patients with ARDS. PEEP aims to counter the pulmon-
ary shunt due to increased lung collapse resulting from
inflammation. High PEEP maintains functional residual
capacity and improves oxygenation [5,6] and may even
have an effect on reducing mortality associated with
ARDS [7,8]. The best strategy to set optimal PEEP for
an individual patient has not yet been established [9,10].
It is unclear whether lung recruitment manoeuvres
(LRM) add benefit to low tidal volume protective venti-
lation strategies in ARDS [11,12]. The most commonly
used LRM requires the application of sustained continu-
ous positive airway pressure (CPAP) at 35 to 40 cm
H2O for 40 seconds [2,13,14]. However, this LRM
method can be uncomfortable, may induce circulatory
depression and has not been associated with improved
outcomes in patients with ARDS [13-15].
We previously demonstrated that a staircase recruit-
ment manoeuvre (SRM) was safe and effective in
improving oxygenation and lung compliance for up to
one hour in patients with ARDS[16]. The SRM involves
a progressive increase in PEEP (up to 40 cm H2O) over
several minutes with mandatory pressure control venti-
lation, resulting in intermittent higher pressures (55 cm
H2O) for longer duration and increased alveolar recruit-
ment compared with static recruitment methods [16].
Borges and co-workers found that oxygenation benefits
of the SRM can be maintained for up to six hours with
the application of “optimal” PEEP using a PEEP titration
manoeuvre [17]. To our knowledge the effect of an
open lung strategy, which includes SRM and PEEP titra-
tion, on inflammatory markers or physiological indices
has not been investigated beyond six hours in patients
with ARDS.
The potentially deleterious higher airway pressures
observed in previous strategies that incorporated high
PEEP and LRMs may be avoided by reducing tidal
volume, a practice that may require permissive hyper-
capnia. It has been demonstrated in animals and
humans that the acidosis induced by this hypercapnia,
independent of any changes in ventilator strategy, may
also confer benefit in ARDS [18-20].
The aim of this pilot trial was to compare an open
lung pressure control ventilation strategy that utilised
SRM, high PEEP and permissive hypercapnia to limit
airway pressures (PHARLAP; Permissive Hypercapnia,
Alveolar Recruitment, Low Airway Pressures) with a
control strategy (conventional ARDSnet ‘protective’
volume controlled ventilation [21]) in patients with
ARDS to determine the effect on inflammatory cyto-
kines, physiological lung injury (arterial oxygenation and
lung compliance) and rates of barotrauma over a seven-
day period.
Materials and methods
This pilot randomised, controlled, parallel-group study
was conducted between January 2008 and October 2009.
The Human Research Ethics Committees of The Alfred
Hospital and Monash University approved the study
protocol. Informed consent was obtained from each
patient’s next of kin.
Twenty mechanically ventilated patients with ARDS
[22] in the Intensive Care Unit of the Alfred Hospital
were enrolled. Patients were randomised to treatment
(PHARLAP) or control groups using sequentially num-
bered sealed opaque envelopes, generated by compu-
terised random block schedule. Patients were stratified
by the diagnosis of severe sepsis according to ACCP/
SCCM Consensus Conference guidelines [23-25].
Inclusion criteria were the diagnosis of ARDS [26,27],
age > 15 years, and the presence of both an intra-arterial
line and central venous catheter. Patients were excluded
if they had chest trauma, an intercostal catheter with air
leak, a pneumothorax on chest x-ray, bronchospasm on
auscultation, raised intracranial pressure, mean arterial
pressure ≤60 mmHg, significant arrhythmias or were
ventilated for longer than 72 hours.
Interventions
PHARLAP ventilation strategy
The PHARLAP strategy included pressure control venti-
lation (PCV), with plateau pressures < 30 cm H2O while
delivering tidal volumes of less than 6 mls/kg ideal body
weight (IBW) with patients in a supine position with 30
degrees head of bed elevation. The fraction of inspired
oxygen (FIO2) was adjusted until the continuously moni-
tored oxygen saturation was 90 to 92%. For the SRM, the
high pressure was set to 15 cm H2O above the PEEP,
which was increased in a stepwise manner to 20, then 30
and then 40 cm H2O every two minutes, and then
reduced to 25, then 22.5, then 20, then 17.5 or then an
absolute minimum of 15 cm H2Oe v e r yt h r e em i n u t e s
until a decrease in SaO2 ≥ 1% from maximum SaO2 was
observed. This was defined as the derecruitment point.
PEEP was then increased to 40 cm H2O for one minute
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cruitment point (which was then defined as optimal
PEEP). Stepwise increases in PEEP did not continue if
the patient became bradycardic or tachycardic (< 60 or >
140 beats per minute), developed a new arrhythmia,
became hypotensive (systolic blood pressure < 80
mmHg) or became hypoxaemic (SaO2 < 85%). Following
this SRM the tidal volume was adjusted to achieve a tidal
volume ≤ 6 mls/kg IBW and a plateau pressure ≤ 30 cm
H2O. Hypercapnia was tolerated and acidosis was only
treated if the pH was less than 7.15 by increasing respira-
tory rate to a maximum of 38 breaths per minute. The
PHARLAP group received one SRM daily (with decre-
mental PEEP titration) until the patient was deemed
ready for weaning. In addition, PEEP was transiently ele-
vated to 40 cm H2O( w i t hP C Va t1 5c mH 2O) for one
minute if oxygen desaturation ≤ 90% occurred or after
disconnection from the ventilator.
Patients were assessed daily for weaning readiness.
Weaning was commenced in both groups when all of
the following occurred: respiratory rate < 35 breaths per
minute, PaO2 >6 0m mH g ,S p O 2 > 90% with fraction
of inspired oxygen < 0.4 and PEEP < 10 cm H2O, mean
arterial pressure > 60 mm Hg without inotrope infu-
sions or sedatives.
Control ventilation strategy
The control group was treated using the ARDSnet proto-
col, with assist control ventilation and FiO2/PEEP titra-
tion [21]. Tidal volumes were limited to 6 mls/kg, plateau
pressures < 30 cm H2O. Acidosis (pH < 7.3) was actively
managed by increasing minute ventilation. PCV was not
used, and recruitment manoeuvres were only allowed if
the patient met the criteria for use of a rescue therapy,
which was when the patient was receiving FiO2 ≥ 0.9,
and the treating clinicians considered one necessary.
Outcome measures
Plasma interleukin-6 (IL-6), interleukin-1b (IL-1b),
interleukin-8 (IL-8) and TNF-a concentrations were
measured from arterial blood samples taken at baseline,
three hours after randomisation and then on days 1, 3, 5
and 7. Samples were immediately centrifuged at 1,500 g
for 10 minutes and plasma aspirated and stored at -70°
C. Cytokines were detected using commercially available
enzyme-linked immune-absorbent assays (ELISA, R&D
Systems, Inc., Minneapolis, MN, USA).
Peak and plateau pressure, tidal volume, respiratory
rate, PEEP, heart rate and rhythm, central venous pres-
sure, blood pressure, inotrope dosage and arterial blood
gases were measured at baseline, 1, 3, 6 and 24 hours
and then daily during the period of mechanical ventila-
tion up to seven days. Derived variables were PaO2/FIO2
ratio and static lung compliance. Length of stay (in ICU
and in hospital), length of mechanical ventilation and
hospital survival for both groups were recorded.
Sample size
The sample size was one of convenience as this was a
pilot study. We estimated that 10 patients per group
would provide > 80% power to detect a difference of
one standard deviation in cytokine levels, with a two-
sided test for differences, a P-value of 0.01 whilst assum-
ing an Intraclass Correlation of 0.2 between baseline
level and Day 3. The intention to treat principle was
utilised.
Statistical analysis
All outcomes were initially assessed for normality and
log-transformed where appropriate. Group comparisons
were made using chi-square tests for equal proportion,
Student t-tests for normally distributed data and Wil-
coxon rank sum tests otherwise, with normally distribu-
ted data reported as means ± standard errors and non-
normal data reported as medians (interquartile range).
Group comparisons over time were performed using
repeated measures analysis of variance fitting an overall
group effect, a time effect and a group by time interac-
tion to ascertain if the groups behaved differently over
time. As cytokine measurements were found to be well
approximated by log-normal distributions, results have
been graphed as geometric means (95% CI) with differ-
ences reported as ratios (95% CI). Where baseline differ-
ences were found to exist, results were analysed using
analysis of covariance with baseline values as a covariate.
All models were fitted using the PROC Mixed proce-
dure in SAS (SAS Version 9.1 SAS Institute Inc., Cary,
NC, USA). To account for possible bias arising from dif-
fering extubation or dropout rates between groups, addi-
tional sensitivity analyses were conducted for
compliance and oxygenation with patients carrying their
last observation forward. A two-sided P-value ≤0.05 was
considered statistically significant.
Results
Twenty patients with ARDS were enrolled (Figure 1).
Baseline demographic data of the control and PHAR-
LAP groups are displayed in Table 1. There were no sta-
tistically significant differences between the groups at
baseline.
In the PHARLAP group, all 10 patients received daily
SRM with maximum PEEP of 40 cm H2Oa n dam a x i -
mum plateau airway pressure of 55 cm H2O. Three
patients transiently desaturated to < 90% at maximum
PEEP of 40 cm H2O with no lasting adverse effects.
There was no radiographic evidence of barotrauma dur-
ing the seven day study period.
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hypoxaemia (SaO2 ≤ 90% whilst receiving FiO2 0.9 and
PEEP 18) and received rescue therapies (a static recruit-
ment manoeuvre in one and inhaled nitric oxide in the
other). One patient in the control group died during the
seven-day intervention period. Five patients in the
PHARLAP group were weaned from mechanical ventila-
tion within the seven days compared to three in the
control group. At Day 7, there were five PHARLAP
group patients and six control group patients who
remained on mechanical ventilation.
There was evidence to suggest that some cytokine
values differed between groups with plasma IL-8 and
TNF-a levels being significantly lower in the PHARLAP
group (Figure 2). Using an analysis of covariance with
baseline values as a covariate, the overall levels of IL-8
over all time points were 41% higher in the control
group compared to the PHARLAP group (ratio 1.41
(1.11 to 1.79), P = 0.01). Similarly, overall levels of TNF-
a over all time points were 20% higher in the control
group compared to the PHARLAP group (ratio 1.20
(1.01 to 1.42), P = 0.05). There were no statistically sig-
nificant differences in IL-6 or IL-1b between the treat-
ment and control groups.
There was a significant overall improvement in static
lung compliance in the PHARLAP group compared to the
control group over seven days (49.1 ± 2.9 versus 33.7 ±
2.7 mls/cm H2O, P <0 . 0 0 1 ,F i g u r e3 ) .P a O 2/FIO2 was
higher in the PHARLAP group than the control group
over the first 24 hours (Figure 4) and over 7 days (204 ± 9
versus 165 ± 9 cm H2O, P = 0.005, Figure 5).
The PEEP was higher in the PHARLAP group over the
first 24 hours (Table 2) and throughout the 7 days
(PHARLAP 12 ± 0.5 cm H2O, control 9.5 ± 0.5, P =
0.004, Table 3) than the control group.
There were no other significant differences between the
groups (Table 3) in respiratory and haemodynamic vari-
ables, peak or plateau pressures, pH, PaCO2 or SOFA
scores during the seven-day period. Of note, the mean pla-
teau pressures were less than 30 cm H2O throughout the
study in both groups and the plateau pressures were no
higher in the PHARLAP group than the control group.
There were no differences in length of ventilation,
length of stay in ICU and length of stay in hospital, or
hospital survival (Table 4).
Discussion
This pilot, randomised controlled study examined the effi-
cacy and safety of a multi-faceted open lung mechanical
Figure 1 Patient flow diagram. AAA, abdominal aortic aneurysm;
COPD, chronic obstructive lung disease; ICP, intracranial pressure;
PaO2/FIO2, partial pressure of oxygen to inspired fraction of oxygen
ratio.
Table 1 Baseline demographic data (mean ± SE)
PHARLAP Control P
Number in group 10 10
Male, number 7 6
Age, years 60 ± 5 58 ± 4 0.65
APACHE 2 score 20.1 ± 3 20.1 ± 2 0.99
APACHE 3 score 66.3 ± 8 64.8 ± 7 0.89
SOFA score 8.6 ± 0.9 8.4 ± 0.5 0.86
PaO2/FIO2, mmHg 155 ± 8 149 ± 12 0.65
Diagnostic group 5 pneumonia 6
pneumonia
2 AAA 2 AAA
1 necrotising
fasciitis
1 burn
2 trauma 1 sepsis
Static lung compliance,
ml/cm H2O
45.8 ± 5.4 37.3 ± 5.4 0.48
PEEP, cm H2O 11.8 ± 0.7 14.2 ± 1.2 0.09
AAA, abdominal aortic aneurysm repair; APACHE, acute physiology and
chronic health evaluation; PEEP, positive end expiratory pressure; SE, standard
error, SOFA, sequential organ failure assessment score
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staircase recruitment manoeuvres, decremental PEEP
titration, low airway pressure and pressure control ventila-
tion in patients with ARDS. The strategy appeared safe
and was associated with ameliorations in plasma IL-8 and
TNF-a levels, improved static lung compliance and
improved oxygenation over a seven-day period. Although
some cytokines were not significantly ameliorated (IL-6
and IL-1b) and unsurprisingly given the size of the study
there were no significant differences in duration of
mechanical ventilation, ICU stay and hospital stay.
Static lung compliance decreased by nearly 30% in the
control strategy group over the first 24 hours and
remained low for the duration of the study compared
with the PHARLAP strategy, which actually resulted in
an increase in compliance. These suggest a greater degree
of lung recruitment was sustained throughout the study
period in the PHARLAP group, an effect which may be
important in ARDS to minimise the potential negative
effects of ventilator induced lung injury.
Systemic arterial oxygenation, as measured by the
PaO2/FIO2, was improved by the PHARLAP strategy
and maintained for seven days. The beneficial effects of
PEEP on oxygenation have been demonstrated by
systematic review and include an association with
improved survival in patients with ARDS [8]. It is
unclear from our results whether the improved oxygena-
tion was as a result of the increased PEEP, the SRM,
both, or another aspect of our multi-pronged strategy.
However, the results of this trial expand on the previous
work by our group which demonstrated that the SRM
with decremental optimal PEEP titration improved lung
compliance and oxygenation over a one hour period in
patients with ARDS [16].
The shorter duration of mechanical ventilation in the
PHARLAP group resulted in smaller group size contri-
buting to the mean values of PaO2/FIO2 and compliance
as days progressed. This may have given the incorrect
appearance of decreasing differences between the two
groups especially considering that patients with better
PaO2/FIO2 and compliance values are more likely to be
extubated. We have attempted to correct for this by
including a sensitivity analysis with last observation car-
ried forward (Figures 3 and 5). In both analyses the dif-
ferences between the PHARLAP and the control
ventilation groups were statistically significant with the
PHARLAP group having higher PaO2/FIO2 and static
lung compliance over seven days.
Figure 2 IL-8 and TNF-a measured over 168 hours (seven days) reported as geometric means (95% CI). There was a significant overall
difference in interleukin-8 and serum tumour necrosis factor-alpha between the treatment group and the control group over the seven-day
period (P = 0.01 and P = 0.05 respectively).
Figure 3 Static lung compliance measured in ventilated patients for seven days (mean ± SE). There was a significant overall improvement
in static lung compliance in the PHARLAP group compared to control group patients. A = missing data analysed as random P = 0.001, B = last
observation carried forward P = 0.01.
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ments would translate into clinically meaningful out-
c o m e ss u c ha si m p r o v e ds u r v i v a l .H o w e v e r ,i no u r
study the use of rescue therapies for severe hypoxaemia
was only required in the control group. Two of the
patients in the control group required nitric oxide and
the application PEEP levels higher than specified by the
control group strategy protocol to maintain adequate
oxygenation.
Although the study protocol advocated permissive
hypercapnia and low airway pressures as components of
the PHARLAP strategy, the mean PaCO2,p Ha n dp l a -
teau pressure values were similar in both the PHARLAP
and control groups. This suggests that these factors
were less likely to have been responsible for the different
outcomes between the groups. The primary differences
in strategies were the application of the recruitment
manoeuvre and the higher PEEP level with a lower driv-
ing pressure (a consequence of higher PEEP and
unchanged plateau pressure) in the PHARLAP group.
This is in contrast to several randomised trials
[13,14,28], in all of which the treatment groups had a
higher plateau pressure in association with a higher
PEEP level, an important factor which may have con-
founded that ability of these high PEEP (± LRM) studies
to detect a difference between groups. Importantly, our
strategy achieved similar peak and plateau airway pres-
sures in both groups despite increased levels of PEEP in
the PHARLAP group.
Transient desaturation at maximum PEEP during
SRMs with subsequent augmentation of oxygen satura-
tion higher than baseline with PEEP reduction has pre-
viously been described by our group [16] and by others
[17]. In this study, maximum PEEP was associated with
transient desaturation in 3 of the 10 patients who
received SRMs. There were no other adverse events
reported. Transient desaturation does not indicate a fail-
ure of the lungs to respond to a recruitment manoeuvre
[16]. The PHARLAP strategy improved lung compliance
and oxygenation despite transient desaturation in these
three patients.
Lung recruitment manoeuvres that involve high airway
pressures to achieve and maintain lung recruitment have
the potential to cause over-distension [29]. Plasma levels
of IL-6, IL-1b,I L - 8a n dT N F - a were analysed to deter-
mine if the SRM caused an increase in inflammatory
markers, which might reflect the systemic effects of over-
distension lung injury. Our results showed that the
PHARLAP strategy resulted in an overall reduction of
plasma IL-8 and TNF-a over seven days that may have
indicated a protective benefit associated with the treat-
ment strategy. To ensure that observed differences
between groups for IL-8 and TNF-a were not due to
baseline imbalances, an analysis of covariance was con-
ducted with baseline values used as covariates. There
were no significant differences for IL-6 and IL-1b,w h i c h
may reflect the large heterogeneity of the patient popula-
tion, the small sample size, or that some cytokine levels
are not affected by this mechanical ventilation strategy.
Although this study was not adequately powered to
determine clinically-meaningful outcomes, it is interesting
to note that the PHARLAP strategy was associated with
Figure 4 PaO2/FIO2 measured over the first 24 hours in
ventilated patients (mean ± SE). PHARLAP group had a significant
overall increase in PaO2/FIO2 compared to control group patients
(*P < 0.01).
Figure 5 PaO2/FIO2 measured over seven days in ventilated patients (mean ± SE). There was a significant overall improvement in PaO2/
FIO2 ratio in PHARLAP compared to control group patients. A = missing data analysed as random, P = 0.005. B = last observation carried
forward, P = 0.03.
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shorter duration of mechanical ventilation, ICU stay and
hospital stay. We feel such pilot study results warrant
investigation in a larger randomized trial. If the PHARLAP
strategy is effective, it may be a safe and cost effective
treatment strategy for patients with ARDS.
This study has a number of limitations. The unblinded
nature of the study, coupled with the use of adjunctive
interventions at the discretion of the intensive care phy-
sician in the case of severe hypoxaemia, may have con-
founded our results. There are several possible
mechanisms for a decrease in SaO2 observed during the
SRM other than atelectasis and increased shunt, which
may lead to a false assumption of developing airway clo-
sure. It is possible that during the incremental pressure
o ft h eS R Mt h e r ew e r er e d u c e dt i d a lv o l u m e sr e s u l t i n g
in increased PaCO2 and arterial desaturation; however,
in a previous study by our group the PaCO2 had
returned to baseline levels at the point of determination
of optimal PEEP [16]. We performed this study in a sin-
gle-centre, which facilitated rigorous education and con-
sistent implementation of the strategy, but may decrease
the generalisability of the results to other populations.
The small sample size meant the study was underpow-
ered to determine differences in length of mechanical
ventilation, ICU stay and hospital stay. It also meant
that despite random allocation the static lung
compliance at baseline was slightly higher and the PEEP
was slightly lower in the PHARLAP group (Table 1).
These differences were not statistically significant, but
may have influenced our results.
Conclusions
This randomized controlled trial showed that a multi-
faceted open lung strategy that was based on staircase
recruitment manoeuvres and decremental PEEP titration
improved plasma cytokines (IL-8 and TNF-a), static
lung compliance and oxygenation over seven days.
There were no differences in duration of mechanical
ventilation, ICU stay or hospital stay; however, further
investigation in a larger randomized trial is warranted.
Key messages
￿ An open lung strategy including staircase recruit-
ment and PEEP titration improved plasma cytokines,
static lung compliance and oxygenation over seven
days
￿ An open lung strategy including staircase recruit-
ment and PEEP titration was safe
￿ Open lung ventilation was associated with a trend
for reduced duration of ventilation that requires
investigation in a larger trial
￿ Open lung ventilation was associated with less use
of rescue therapies
Table 3 Respiratory variables during seven days of treatment (mean ± SE) * P <0
Baseline Day 1 Day 3 Day 7
PHARLAP Control PHARLAP Control PHARLAP Control PHARLAP Control
VT, mls 519 ± 56 501 ± 30 463 ± 42 563 ± 65 586 ± 58 511 ± 55 528 ± 76 579 ± 78
RR, bpm 21 ± 2 21 ± 1 22 ± 2 20 ± 2 19 ± 2 24 ± 2 22 ± 2 22 ± 2
FiO2 0.48 ± 0.06 0.57 ± 0.06 0.4 ± 0.04 0.5 ± 0.04 0.5 ± 0.07 0.55 ± 0.06 0.5 ± 0.07 0.5 ± 0.09
PEEP,
cm H2O
11.8 ± 0.7 14.2 ± 1.2 15 ± 1* 10 ± 0.5 12.1 ± 1.5 9.3 ± 1.4 8.5 ± 1.8 7.8 ± 2.0
Pplateau, cmH2O 28.4 ± 1.5 29 ± 1.5 27.6 ± 1.5 26.9 ± 1.4 24.2 ± 2.4 24 ± 2.1 21 ± 2.9 20. ± 3.4
Arterial pH 7.34 ± 0.02 7.36 ± 0.02 7.36 ± 0.01 7.35 ± 0.01 7.38 ± 0.03 7.44 ± 0.03 7.42 ± 0.03 7.42 ± 0.04
PaCO2, mmHg 49 ± 5 46 ± 5 45 ± 3 46 ± 3 47.6 ± 3.7 44 ± 3.5 43.3 ± 4 56.5 ± 5
Vt, tidal volume; RR, respiratory rate; FIO2, fraction of inspired oxygen; PEEP, positive end expiratory pressure; Pplateau, plateau pressure; PaCO2, partial pressure
of carbon dioxide
Table 2 Respiratory variables during the first 24 hrs of treatment (mean ± SE)
1 hour 3 hours 6 hours 24 hours
PHARLAP Control PHARLAP Control PHARLAP Control PHARLAP Control
VT, mls 519 ± 56 501 ± 30 517 ± 51 529 ± 58 529 ± 56 542 ± 49 463 ± 42 563 ± 65
RR, bpm 21 ± 2 21 ± 1 20 ± 2 21 ± 2 21 ± 2 21 ± 2 22 ± 2 20 ± 2
FIO2 0.47 ± 0.03 0.59 ± 0.04 0.5 ± 0.04 0.5 ± 0.03 0.4 ± 0.05 0.57 ± 0.05 0.4 ± 0.04 0.5 ± 0.04
PEEP, cm H2O 17.4 ± 1 11.6 ± 1 17.4 ± 1* 11 ± 0.5 16.7 ± 1* 10 ± 0.6 15 ± 1* 10 ± 0.5
Pplateau, cm H2O 28.9 ± 1.2 27.1 ± 1.2 28.3 ± 1.1 26.6 ± 1.1 29 ± 0.8 26 ± 0.8 27.6 ± 1.5 26.9 ± 1.4
Arterial pH 7.34 ± 0.02 7.36 ± 0.02 7.34 ± 0.02 7.34 ± 0.03 7.34 ± 0.02 7.36 ± 0.01 7.36 ± 0.01 7.35 ± 0.01
PaCO2,m mH g 4 9±5 4 6±5 4 7±4 4 8±6 4 8±3 4 5±3 4 5±3 4 6±3
*P < 0.05 for differences between PHARLAP and control groups.
VT, tidal volume; RR, respiratory rate; FIO2, fraction of inspired oxygen; PEEP, positive end expiratory pressure; Pplateau, plateau pressure; PaO2/FIO2, partial
pressure of oxygen to inspired fraction of oxygen ratio; PaCO2, partial pressure of carbon dioxide
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ARDS: acute respiratory distress syndrome; ARDSnet: Acute Respiratory Distress
Syndrome Network; CI: confidence interval; FIO2: fraction of inspired oxygen; IBW:
ideal body weight; ICU: intensive care unit; IL-6: interleukin-6; IL-8: interleukin-8;
IL-1β: interleukin-1β;P a C O 2: partial pressure of carbon dioxide; PaO2:p a r t i a l
pressure of oxygen; PaO2/FIO2: ratio of partial pressure of oxygen to fraction of
inspired oxygen; PCV: pressure control ventilation; PEEP: positive end expiratory
pressure; PHARLAP: open lung ventilation strategy with Permissive Hypercapnia
and Alveolar Recruitment and Low Airway Pressure; SaO2: arterial oxygen
saturation; SE: standard error; SRM: staircase recruitment manoeuvre; SOFA:
Sequential Organ Failure Assessment score; TNF-α: tumour necrosis factor-alpha;
VCV: volume controlled ventilation.
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